Nations Trust Bank Plc. Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: Nations Trust Bank Plc. Pharmaceutical Import Records from India — 2 Products, $657.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nations Trust Bank Plc. — Pharmaceutical Importer Profile (2026) | 2 Products, $657.9K Trade | TransData Nexus

Nations Trust Bank Plc.

Pharmaceutical Importer · Sri Lanka · Immunosuppressants Focus · $657.9K Total Trade · DGFT Verified

Nations Trust Bank Plc. is a pharmaceutical importer based in Sri Lanka with a total trade value of $657.9K across 2 products in 2 therapeutic categories. Based on 14 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Nations Trust Bank Plc. sources from 5 verified Indian suppliers, with Torrent Pharmaceuticals Limited accounting for 78.1% of imports.

Nations Trust Bank Plc. — Import Portfolio & Supplier Network

Nations Trust Bank Plc. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Nations Trust Bank Plc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$1.1M	48	78.1%
Gufic Biosciences Limited	$219.5K	10	14.9%
Msn Laboratories Private Limited

What Formulations Does Nations Trust Bank Plc. Import?

Formulation	Value	Ships
Lefra 10 tablet(leflunomide 10MG	$448.7K	10
Mosid mt 5 tablet (mosapride citrate 5MG	$181.0K	5
Nexpro 40 tablet (esomeprazole	$100.0K	2
Merofic 1g INJ (meropenem injection 1g)	$100.0K	2
Merofic 1g meropenem injection 1g	$100.0K	2
Torcoxia bcd 90 tablet(etoricoxib 90MG)	$60.0K	2
Valparin 200 alkalets tablet (sodium	$50.0K	1
Dilzem 30 tablet (diltiazem hcl 30MG	$37.8K	7
Deplatt 75 tablet(clopidogrel	$34.0K	2
Telday 20 tablet (telmisartan 20 MG)	$30.3K	1
Nexpro 20MG tablet (esomeprazole	$30.0K	1
Velparin chrono 500 tablet(sodium	$27.4K	2
Dilzem sr tablet (diltiazem	$27.1K	2
Pharma product:novapreg-150[pregabalin capsules 150 MG]batchno. i422e4002 mfg &exp date:mar-24 &	$26.4K	1
Glyxambi 10/5MG (Each film coated	$24.4K	1

Nations Trust Bank Plc. imports 34 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Leflunomide	Immunosuppressants	$457.9K	10	3.1%	4
2	Meropenem	Advanced Antibiotics	$200.0K	4	0.1%	12

Nations Trust Bank Plc. imports 2 pharmaceutical products across 2 categories into Sri Lanka totaling $657.9K.

Nations Trust Bank Plc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Nations Trust Bank PLC (NTB) is a prominent commercial bank in Sri Lanka, established in July 1999 following the acquisition of the Colombo branch of Overseas Trust Bank Ltd. Headquartered in Colombo, the bank offers a comprehensive suite of banking services, including consumer, commercial, and corporate banking, as well as treasury and fund management. NTB is also the issuer and sole acquirer of American Express Cards in Sri Lanka, holding a significant position in the premium market segments.

While NTB's primary focus is on banking services, its involvement in pharmaceutical imports is not prominently documented. The available trade data indicates that NTB has engaged in importing finished pharmaceutical formulations from India, with a total import value of $658,000 USD across 14 shipments. This suggests that NTB may operate as a buyer or intermediary in the pharmaceutical supply chain, facilitating the procurement of specific pharmaceutical products for distribution within Sri Lanka.

2Distribution Network

NTB's distribution network is primarily centered around its banking operations, with 96 branches and 99 ATMs across Sri Lanka. However, specific details regarding warehouse locations, logistics capabilities, and geographic coverage related to pharmaceutical imports are not publicly available. Given the limited data, it is challenging to provide a comprehensive analysis of NTB's distribution network in the pharmaceutical sector.

3Industry Role

NTB's role in Sri Lanka's pharmaceutical supply chain appears to be that of a buyer or intermediary, importing finished pharmaceutical formulations from Indian suppliers. The trade data reveals that NTB has engaged in importing specific pharmaceutical products, such as Leflunomide and Meropenem, indicating a targeted approach to sourcing these medications. This suggests that NTB may not function as a primary wholesaler or parallel importer but rather as a facilitator in the procurement and distribution of certain pharmaceutical products within the Sri Lankan market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Nations Trust Bank Plc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

NTB's pharmaceutical sourcing is highly concentrated, with a total import value of $658,000 USD across 14 shipments, all sourced from India. The top five products imported account for 100% of the total import value, indicating a complete reliance on these specific products. This level of concentration could pose risks, such as supply chain disruptions or dependency on a limited number of suppliers. However, the stability of NTB's relationships with its Indian suppliers, as evidenced by multiple shipments from each, suggests a strategic choice to maintain consistent quality and supply for these critical medications.

2Supply Chain Resilience

NTB's pharmaceutical supply chain appears to be heavily reliant on a single source—India—for its imports. The data indicates that all pharmaceutical products are sourced from Indian suppliers, with no backup suppliers identified. This lack of diversification could expose NTB to risks associated with geopolitical tensions, regulatory changes, or logistical disruptions affecting the Indian supply chain. Additionally, the absence of information regarding the regulatory compliance of key suppliers and shipping route exposure further underscores the need for NTB to consider diversifying its supply chain to enhance resilience.

Strategic Implications

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

In Sri Lanka, the National Medicines Regulatory Authority (NMRA) is the primary body responsible for regulating pharmaceuticals, ensuring that all imported and locally manufactured medicines meet safety, efficacy, and quality standards. The NMRA operates under the Ministry of Health and is guided by the National Medicines Regulatory Authority Act, No. 5 of 2015. This legislation outlines the procedures for the registration, importation, and distribution of pharmaceutical products within Sri Lanka.

For Indian pharmaceutical companies seeking to export to Sri Lanka, obtaining marketing authorization from the NMRA is mandatory. The process involves submitting detailed product dossiers, including clinical trial data, manufacturing information, and quality control measures. The NMRA evaluates these submissions to ensure compliance with Sri Lankan standards before granting approval for importation and sale.

2Import Licensing & GMP

Import licensing in Sri Lanka is governed by the NMRA, which requires all pharmaceutical imports to be accompanied by a valid import license. To obtain this license, importers must provide evidence that the products have been registered with the NMRA and that they comply with the necessary quality standards. Good Manufacturing Practice (GMP) certification is a critical component of this process.

Nations Trust Bank Plc. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

NTB's focus on importing specific pharmaceutical products, such as Leflunomide and Meropenem, indicates a strategic approach to meet targeted market demands. Leflunomide is commonly used in the treatment of rheumatoid arthritis, while Meropenem is a broad-spectrum antibiotic used in the treatment of severe infections. The importation of these products suggests that NTB is catering to the needs of patients requiring specialized treatments, possibly in collaboration with healthcare providers or institutions.

The market demand for these medications is driven by the prevalence of conditions like rheumatoid arthritis and severe infections in Sri Lanka. By focusing on these therapeutic areas, NTB aims to address critical healthcare needs and position itself as a key player in providing essential medicines to the Sri Lankan population.

2Sourcing Profile

NTB's sourcing strategy for pharmaceutical products is centered on importing finished formulations from India. This approach allows NTB to leverage India's established pharmaceutical manufacturing capabilities and cost advantages. By focusing on specific formulations, NTB can ensure a consistent supply of high-quality products tailored to the needs of the Sri Lankan market.

India's role as a major global supplier of generic pharmaceuticals aligns with NTB's procurement strategy, enabling the bank to access a wide range of products at competitive prices. This sourcing profile reflects NTB's commitment to providing essential medicines to the Sri Lankan market while maintaining cost-effectiveness and quality standards.

Seller's Guide — How to Become a Supplier to Nations Trust Bank Plc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with NTB, particularly if they can offer high-quality pharmaceutical products that align with NTB's current import portfolio. NTB's focused sourcing strategy suggests that it is open to partnerships that can provide specialized medications meeting the needs of the Sri Lankan market.

Potential gaps in NTB's current sourcing include a limited range of therapeutic areas and formulations. Indian exporters can explore these gaps by offering products in other high-demand therapeutic categories or by providing alternative formulations that complement NTB's existing imports. By addressing these areas, new suppliers can position themselves as valuable partners to NTB, contributing to the diversification

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Nations Trust Bank Plc.

What products does Nations Trust Bank Plc. import from India?

Nations Trust Bank Plc. imports 2 pharmaceutical products across 2 categories. Top imports: Leflunomide ($457.9K), Meropenem ($200.0K).

Who supplies pharmaceuticals to Nations Trust Bank Plc. from India?

Nations Trust Bank Plc. sources from 5 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (78.1% of imports, $1.1M).

What is Nations Trust Bank Plc.'s total pharmaceutical import value?

Nations Trust Bank Plc.'s total pharmaceutical import value from India is $657.9K, based on 14 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Nations Trust Bank Plc. focus on?

Nations Trust Bank Plc. imports across 2 categories. The largest: Immunosuppressants (69.6%), Advanced Antibiotics (30.4%).

Get Full Nations Trust Bank Plc. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.